Wound Management Technologies Inc  

(Public, OTCMKTS:WNDM)   Watch this stock  
Find more results for PINK:WNDM
+0.0088 (14.67%)
Jul 22 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.07 - 0.07
52 week 0.02 - 0.09
Open 0.07
Vol / Avg. 1,000.00/11,229.00
Mkt cap 8.77M
P/E     -
Div/yield     -
EPS -0.01
Shares 108.38M
Beta 0.22
Inst. own 0%

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 8.24% -39.75%
Operating margin 12.68% -34.50%
EBITD margin - -26.84%
Return on average assets 24.83% -92.76%
Return on average equity - -
Employees 4 -
CDP Score - -


777 Main St Ste 3100
FORT WORTH, TX 76102-5325
United States - Map
+1-817-8207080 (Phone)

Website links


Wound Management Technologies, Inc., formerly MB Software, Inc., distributes collagen-based wound care products to healthcare providers, such as physicians, clinics and hospitals. The Company's subsidiaries include Wound Care Innovations, LLC (WCI), Resorbable Orthopedic Products, LLC and Innovate OR, Inc. The Company's WCI provides CellerateRX product in the wound care market. CellerateRX is a medical device for use on all acute and chronic wounds, except third degree burns. CellerateRX is offered in both gel and powder form. WCI expanded its CellerateRX product line to include CellerateRX Surgical products.

Officers and directors

Deborah Jenkins Hutchinson President
Age: 56
Darren Stine Chief Financial Officer
Age: 44
Cathy Bradshaw President of Wound Care Innovations, LLC
Age: 61
S. Oden Howell Jr. Director
Age: 75
James W. Stuckert Director
Age: 77
Philip J. Rubinfeld Independent Director
Age: 59
John Siedhoff Independent Director
Age: 55